Thermo Fisher Scientific (TMO) was Reiterated by Mizuho to “Buy” according to the research note released today. The brokerage firm has raised the Price Target to $ 170 from a previous price target of $166 . Mizuho advised their investors in a research report released on May 27, 2016.
Many Wall Street Analysts have commented on Thermo Fisher Scientific. Company shares were Reiterated by Mizuho on May 19, 2016 to “Buy”, Firm has raised the Price Target to $ 166 from a previous price target of $163 .Company shares were Reiterated by Mizuho on May 3, 2016 to “Buy”, Firm has raised the Price Target to $ 163 from a previous price target of $160 .Thermo Fisher Scientific was Downgraded by Jefferies to ” Hold” on Apr 29, 2016.
On the company’s financial health, Thermo Fisher Scientific reported $1.80 EPS for the quarter, beating the analyst consensus estimate by $ 0.06 according to the earnings call on Apr 28, 2016. Analyst had a consensus of $1.74. The company had revenue of $4294.80 million for the quarter, compared to analysts expectations of $4113.28 million. The company’s revenue was up 9.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.63 EPS.
Thermo Fisher Scientific opened for trading at $150.84 and hit $151.68 on the upside on Wednesday, eventually ending the session at $151.16, with a gain of 0.32% or 0.48 points. The heightened volatility saw the trading volume jump to 13,11,933 shares. Company has a market cap of $59,483 M.
Investors should note that on May 18, 2016, Thermo Fisher Scientific announced a cash dividend of $0.1500. The company’s management has announced Jun 13, 2016 as the ex-dividend date and fixed the record date on Jun 15, 2016. The payable date has been fixed on Jul 15, 2016.
In a different news, on May 26, 2016, Stephen Williamson (Sr. VP and CFO) sold 8,660 shares at $150.25 per share price. According to the SEC, on May 17, 2016, Peter E Hornstra (VP & Chief Accounting Officer) sold 7,811 shares at $150.00 per share price. On Apr 27, 2016, Daniel P Shine (Senior Vice President) sold 6,013 shares at $146.00 per share price, according to the Form-4 filing with the securities and exchange commission.
Thermo Fisher Scientific Inc. is a provider of analytical instruments equipment reagents and consumables software and services for research manufacturing analysis discovery and diagnostics. The company operates through four segments: Life Sciences Solutions provides reagents instruments and consumables used in biological and medical research discovery and production of new drugs and vaccines as well as diagnosis of disease; Analytical Instruments provides instruments consumables software and services that are used in the laboratory; Specialty Diagnostics offers diagnostic test kits reagents culture media instruments and associated products and Laboratory Products and Services offers self-manufactured and sourced products for the laboratory.